- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Phone consultations
Last updated: 16 Apr 2020
Tariq Ahmad is a Consultant Gastroenterologist at the Royal Devon and Exeter NHS Foundation Trust, and Honorary Associate Professor at the University of Exeter Medical School.
He qualified from Bristol University in 1992 and completed higher specialist training in gastroenterology in Oxford in 2005.
Dr Ahmad sees private patients at the Exeter Gut clinic, based at 1 The Quadrant in central Exeter. Dr Ahmad has a particular interest and expertise in diagnostic gastroenterology and the management of Crohn’s disease, ulcerative colitis, coeliac disease and irritable bowel syndrome (IBS). Dr Ahmad undertakes all diagnostic endoscopy himself and works closely with radiological, surgical, and dietician colleagues to ensure prompt investigation and treatment whatever the cause of your symptoms.
Private appointments are available within 10 days for patients with private insurance or for self-pay patients. Please contact Karen on 01392 272951. Dr Ahmad is a recognised provider for all major UK health insurance companies.
Areas of interest
Inflammatory bowel disease; irritable bowel syndrome; coeliac disease; dyspepsia; anaemia; diagnostic endoscopy
- Karen Allsopp
- Nuffield Health Exeter Hospital Wonford Road Exeter EX2 4UG
- 01392 796880
- 01392 891068
Anaesthetists worked with
Current NHS consultant posts held
Consultant Gastroenterologist, Royal Devon and Exeter NHS Foundation Trust
Honorary Associate Professor, University of Exeter Medical School
Dr Ahmad leads a research group at the University of Exeter Medical School. His work is focused on the development and implementation of genetic and serological tests to allow individualised treatment strategies for patients with Inflammatory bowel disease, maximizing benefit and minimising harm.
Walking and playing tennis
Bronze national clinical excellence award 2018
Research grants of £3M since 2012
1: Samaan M. Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science? Expert Opin Biol Ther. 2018 Dec;18(12):1271-1279.
2: Walker GJ. Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study. Aliment Pharmacol Ther. 2018 Apr;47(8):1103-1116.
3: Mowat C. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial. Lancet Gastroenterol Hepatol. 2016 Dec;1(4):273-282.
4: Heerasing N. Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease. Aliment Pharmacol Ther. 2017 Mar;45(5):660-669.
5: Carrieri D, Ethical issues and best practice in clinically based genomic research: Exeter Stakeholders Meeting Report. J Med Ethics. 2016 Nov;42(11):695-697.
6: Lee JC. Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease. Nat Genet. 2017 Feb;49(2):262-268
7: Kennedy NA. UK Anti-TNF withdrawal study group, Lees CW. Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis. Aliment Pharmacol Ther. 2016 Apr;43(8):910-923.
8: Heap GA. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease. J Crohns Colitis. 2016 Feb;10(2):149-58.
9: Cleynen I. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016 Jan 9;387(10014):156-67.
10: Gasche C. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis. 2015 Mar;21(3):579-88.
11: Heap GA. HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nat Genet. 2014 Oct;46(10):1131-4.
- DPhil University of Oxford 2003
- FRCP Royal College of Physicians 2011
- M.B. Ch.B. University of Bristol 1992
Reference number 3681479
Affiliations / memberships
European Crohn's and Colitis Organisation
British Society of Gastroenterology
British Association of Parenteral and Enteral Nutrition
- Wonford RoadEXETEREX2 4UG
- 13:00 - 18:00
- 01392 796880
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.